Hualan Biological Engineering Inc
SZSE:002007

Watchlist Manager
Hualan Biological Engineering Inc Logo
Hualan Biological Engineering Inc
SZSE:002007
Watchlist
Price: 16.48 CNY 0.18% Market Closed
Market Cap: 30.1B CNY
Have any thoughts about
Hualan Biological Engineering Inc?
Write Note

Hualan Biological Engineering Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hualan Biological Engineering Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Hualan Biological Engineering Inc
SZSE:002007
Operating Income
ÂĄ1.6B
CAGR 3-Years
-9%
CAGR 5-Years
0%
CAGR 10-Years
12%
Beigene Ltd
HKEX:6160
Operating Income
-ÂĄ8.8B
CAGR 3-Years
8%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Operating Income
ÂĄ2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Operating Income
ÂĄ1.4B
CAGR 3-Years
22%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Operating Income
ÂĄ2.3B
CAGR 3-Years
31%
CAGR 5-Years
46%
CAGR 10-Years
23%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Operating Income
ÂĄ4.3B
CAGR 3-Years
-27%
CAGR 5-Years
11%
CAGR 10-Years
42%
No Stocks Found

Hualan Biological Engineering Inc
Glance View

Market Cap
30.1B CNY
Industry
Biotechnology

Hualan Biological Engineering, Inc. engages in the research and development, production, and sale of biological products. The company is headquartered in Xinxiang, Henan and currently employs 2,927 full-time employees. The company went IPO on 2004-06-25. The company also produces vaccine products and biological engineering products. The firm's main products include human albumins, human immunoglobulin for intravenous injection, human immunoglobulin, human coagulation factors, human rabies immunoglobulin, human tetanus immunoglobulin and influenza vaccines, among others. The firm mainly operates its businesses in domestic markets.

Intrinsic Value
26.95 CNY
Undervaluation 39%
Intrinsic Value
Price

See Also

What is Hualan Biological Engineering Inc's Operating Income?
Operating Income
1.6B CNY

Based on the financial report for Sep 30, 2024, Hualan Biological Engineering Inc's Operating Income amounts to 1.6B CNY.

What is Hualan Biological Engineering Inc's Operating Income growth rate?
Operating Income CAGR 10Y
12%

Over the last year, the Operating Income growth was 4%. The average annual Operating Income growth rates for Hualan Biological Engineering Inc have been -9% over the past three years , and 12% over the past ten years .

Back to Top